{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T12:13:40Z","timestamp":1793708020159,"version":"4.6.1"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,7,26]],"date-time":"2024-07-26T00:00:00Z","timestamp":1721952000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,7,26]],"date-time":"2024-07-26T00:00:00Z","timestamp":1721952000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"\u201cShuguang Program\u201d supported by Shanghai Education Development Foundation and Shanghai Municipal Education Commission","award":["20SG38"],"award-info":[{"award-number":["20SG38"]}]},{"name":"Shanghai Municipal Science and Technology Committee of Shanghai outstanding academic leaders plan","award":["20XD1423300"],"award-info":[{"award-number":["20XD1423300"]}]},{"name":"General Program of National Nature Science Foundation of China","award":["82070036"],"award-info":[{"award-number":["82070036"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Cisplatin (DDP) chemotherapy is commonly used in therapy for non-small cell lung cancer (NSCLC), but increased drug resistance has become a huge obstacle. Baicalin (BA) contributed to the sensitivity of NSCLC to DDP. Here, we aimed to further probe the pathophysiological mechanisms of BA in NSCLC.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A549 and A549\/DDP cells and xenograft mice were treated with BA and DDP. Xenograft mice were treated additionally with the NRF2 inducer (Bardoxolone methyl, BM) and KEAP1 knockdown. The levels of ferritinophagy-related proteins and biomarkers were determined. The autophagosomes were observed. M1 macrophage polarization and the contents of related indicators were analyzed. The involvement of KEAP1\/NRF2\/HO-1 was determined.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>BA inhibited cell development, and the effect of BA and DDP on cell development was additive. The abundance of ferritinophagy-related proteins and the number of autophagosomes were induced by BA. BA also promoted the transition of GSH to GSSH. BA favored M1 macrophage polarization and affected the expression of related proteins. When BA and DDP combined, these molecular phenomena were further exacerbated. BA induced accumulation of KEAP1 and reduction of NRF2 and HO-1. However, BM and KEAP1 knockdown disrupted the synergistic effects of BA and DDP on inhibiting NSCLC growth. BM and KEAP1 knockdown reversed DDP and BA-promoted protein expression activity and M1 macrophage polarization.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Our findings suggest that BA is involved in ferritinophagy and macrophage immunity through the KEAP1-NRF2\/HO-1 axis, thereby improving the DDP sensitivity in NSCLC, which could provide new candidates for treatment strategies.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s40001-024-01930-4","type":"journal-article","created":{"date-parts":[[2024,7,26]],"date-time":"2024-07-26T20:02:40Z","timestamp":1722024160000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Baicalin promotes the sensitivity of NSCLC to cisplatin by regulating ferritinophagy and macrophage immunity through the KEAP1-NRF2\/HO-1 pathway"],"prefix":"10.1186","volume":"29","author":[{"given":"Yang","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shujun","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongzhao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,26]]},"reference":[{"key":"1930_CR1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22168661","author":"R Nooreldeen","year":"2021","unstructured":"Nooreldeen R, Bach H. Current and future development in lung cancer diagnosis. Int J Mol Sci. 2021. https:\/\/doi.org\/10.3390\/ijms22168661.","journal-title":"Int J Mol Sci"},{"key":"1930_CR2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21176329","author":"A Friedlaender","year":"2020","unstructured":"Friedlaender A, Addeo A, Russo A, Gregorc V, Cortinovis D, Rolfo CD. Targeted therapies in early stage NSCLC: hype or hope? Int J Mol Sci. 2020. https:\/\/doi.org\/10.3390\/ijms21176329.","journal-title":"Int J Mol Sci"},{"key":"1930_CR3","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.ctrv.2016.01.003","volume":"44","author":"DA Fennell","year":"2016","unstructured":"Fennell DA, Summers Y, Cadranel J, Benepal T, Christoph DC, Lal R, Das M, Maxwell F, Visseren-Grul C, Ferry D. Cisplatin in the modern era: the backbone of first-line chemotherapy for non-small cell lung cancer. Cancer Treat Rev. 2016;44:42\u201350.","journal-title":"Cancer Treat Rev"},{"issue":"42","key":"1930_CR4","doi-asserted-by":"publisher","first-page":"72544","DOI":"10.18632\/oncotarget.19881","volume":"8","author":"L MacDonagh","year":"2017","unstructured":"MacDonagh L, Gallagher MF, Ffrench B, Gasch C, Breen E, Gray GS, Nicholson S, Leonard N, Ryan R, Young V, et al. Targeting the cancer stem cell marker, aldehyde dehydrogenase 1, to circumvent cisplatin resistance in NSCLC. Oncotarget. 2017;8(42):72544\u201363.","journal-title":"Oncotarget"},{"issue":"3","key":"1930_CR5","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/j.cell.2017.08.051","volume":"171","author":"L Bar-Peled","year":"2017","unstructured":"Bar-Peled L, Kemper EK, Suciu RM, Vinogradova EV, Backus KM, Horning BD, Paul TA, Ichu TA, Svensson RU, Olucha J, et al. Chemical proteomics identifies druggable vulnerabilities in a genetically defined cancer. Cell. 2017;171(3):696\u2013709623.","journal-title":"Cell"},{"issue":"12","key":"1930_CR6","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1038\/nrd4002","volume":"12","author":"C Gorrini","year":"2013","unstructured":"Gorrini C, Harris IS, Mak TW. Modulation of oxidative stress as an anticancer strategy. Nat Rev Drug Discov. 2013;12(12):931\u201347.","journal-title":"Nat Rev Drug Discov"},{"key":"1930_CR7","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.00099-20","author":"L Baird","year":"2020","unstructured":"Baird L, Yamamoto M. The molecular mechanisms regulating the KEAP1-NRF2 pathway. Mol Cell Biol. 2020. https:\/\/doi.org\/10.1128\/MCB.00099-20.","journal-title":"Mol Cell Biol"},{"key":"1930_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13010046","author":"K Taguchi","year":"2020","unstructured":"Taguchi K, Yamamoto M. The KEAP1-NRF2 system as a molecular target of cancer treatment. Cancers (Basel). 2020. https:\/\/doi.org\/10.3390\/cancers13010046.","journal-title":"Cancers (Basel)"},{"issue":"3","key":"1930_CR9","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1080\/14728222.2019.1559824","volume":"23","author":"B Zhang","year":"2019","unstructured":"Zhang B, Ma Z, Tan B, Lin N. Targeting the cell signaling pathway Keap1-Nrf2 as a therapeutic strategy for adenocarcinomas of the lung. Expert Opin Ther Targets. 2019;23(3):241\u201350.","journal-title":"Expert Opin Ther Targets"},{"key":"1930_CR10","doi-asserted-by":"publisher","first-page":"21","DOI":"10.2147\/DDDT.S269277","volume":"15","author":"J Wang","year":"2021","unstructured":"Wang J, Zhang X, Yang F, Yang Y, Wang T, Liu W, Zhou H, Zhao W. RASSF1A enhances chemosensitivity of NSCLC cells through activating autophagy by regulating MAP1S to inactivate Keap1-Nrf2 pathway. Drug Des Devel Ther. 2021;15:21\u201335.","journal-title":"Drug Des Devel Ther"},{"issue":"11","key":"1930_CR11","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1038\/s41419-019-2064-5","volume":"10","author":"E Park","year":"2019","unstructured":"Park E, Chung SW. ROS-mediated autophagy increases intracellular iron levels and ferroptosis by ferritin and transferrin receptor regulation. Cell Death Dis. 2019;10(11):822.","journal-title":"Cell Death Dis"},{"issue":"13","key":"1930_CR12","doi-asserted-by":"publisher","first-page":"12943","DOI":"10.18632\/aging.103378","volume":"12","author":"H Dong","year":"2020","unstructured":"Dong H, Qiang ZZ, Chai DD, Peng JL, Xia YY, Hu R, Jiang H. Nrf2 inhibits ferroptosis and protects against acute lung injury due to intestinal ischemia reperfusion via regulating SLC7A11 and HO-1. Aging (Albany NY). 2020;12(13):12943\u201359.","journal-title":"Aging (Albany NY)"},{"key":"1930_CR13","doi-asserted-by":"publisher","first-page":"101107","DOI":"10.1016\/j.redox.2019.101107","volume":"23","author":"M Dodson","year":"2019","unstructured":"Dodson M, Castro-Portuguez R, Zhang DD. NRF2 plays a critical role in mitigating lipid peroxidation and ferroptosis. Redox Biol. 2019;23:101107.","journal-title":"Redox Biol"},{"key":"1930_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph18105243","author":"NA Alsharairi","year":"2021","unstructured":"Alsharairi NA. Scutellaria baicalensis and their natural flavone compounds as potential medicinal drugs for the treatment of nicotine-induced non-small-cell lung cancer and asthma. Int J Environ Res Public Health. 2021. https:\/\/doi.org\/10.3390\/ijerph18105243.","journal-title":"Int J Environ Res Public Health"},{"issue":"1","key":"1930_CR15","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3892\/ijo.2016.3768","volume":"50","author":"Z Xu","year":"2017","unstructured":"Xu Z, Mei J, Tan Y. Baicalin attenuates DDP (cisplatin) resistance in lung cancer by downregulating MARK2 and p-Akt. Int J Oncol. 2017;50(1):93\u2013100.","journal-title":"Int J Oncol"},{"key":"1930_CR16","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.12659\/MSM.909627","volume":"24","author":"J You","year":"2018","unstructured":"You J, Cheng J, Yu B, Duan C, Peng J. Baicalin, a Chinese herbal medicine, inhibits the proliferation and migration of human non-small cell lung carcinoma (NSCLC) cells, A549 and H1299, by activating the SIRT1\/AMPK signaling pathway. Med Sci Monit. 2018;24:2126\u201333.","journal-title":"Med Sci Monit"},{"key":"1930_CR17","doi-asserted-by":"publisher","first-page":"112105","DOI":"10.1016\/j.biopha.2021.112105","volume":"143","author":"Y Xiao","year":"2021","unstructured":"Xiao Y, Zhang L, Zhu J, Zhang Y, Yang R, Yan J, Huang R, Zheng C, Xiao W, Huang C, et al. Predicting the herbal medicine triggering innate anti-tumor immunity from a system pharmacology perspective. Biomed Pharmacother. 2021;143:112105.","journal-title":"Biomed Pharmacother"},{"key":"1930_CR18","doi-asserted-by":"publisher","first-page":"105387","DOI":"10.1016\/j.phrs.2020.105387","volume":"164","author":"S Singh","year":"2021","unstructured":"Singh S, Meena A, Luqman S. Baicalin mediated regulation of key signaling pathways in cancer. Pharmacol Res. 2021;164:105387.","journal-title":"Pharmacol Res"},{"issue":"1","key":"1930_CR19","doi-asserted-by":"publisher","first-page":"11551","DOI":"10.1038\/s41598-017-10443-6","volume":"7","author":"C Hong","year":"2017","unstructured":"Hong C, Cao J, Wu CF, Kadioglu O, Schuffler A, Kauhl U, Klauck SM, Opatz T, Thines E, Paul NW, et al. The Chinese herbal formula free and easy wanderer ameliorates oxidative stress through KEAP1-NRF2\/HO-1 pathway. Sci Rep. 2017;7(1):11551.","journal-title":"Sci Rep"},{"key":"1930_CR20","doi-asserted-by":"publisher","first-page":"2252","DOI":"10.1016\/j.biopha.2018.11.095","volume":"109","author":"Y Wu","year":"2019","unstructured":"Wu Y, Wang D, Yang X, Fu C, Zou L, Zhang J. Traditional Chinese medicine Gegen Qinlian decoction ameliorates irinotecan chemotherapy-induced gut toxicity in mice. Biomed Pharmacother. 2019;109:2252\u201361.","journal-title":"Biomed Pharmacother"},{"issue":"1\u20133","key":"1930_CR21","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.ejphar.2009.12.014","volume":"630","author":"G Du","year":"2010","unstructured":"Du G, Han G, Zhang S, Lin H, Wu X, Wang M, Ji L, Lu L, Yu L, Liang W. Baicalin suppresses lung carcinoma and lung metastasis by SOD mimic and HIF-1alpha inhibition. Eur J Pharmacol. 2010;630(1\u20133):121\u201330.","journal-title":"Eur J Pharmacol"},{"key":"1930_CR22","doi-asserted-by":"publisher","first-page":"153370","DOI":"10.1016\/j.phymed.2020.153370","volume":"80","author":"JS Lou","year":"2021","unstructured":"Lou JS, Zhao LP, Huang ZH, Chen XY, Xu JT, Tai WC, Tsim KWK, Chen YT, Xie T. Ginkgetin derived from Ginkgo biloba leaves enhances the therapeutic effect of cisplatin via ferroptosis-mediated disruption of the Nrf2\/HO-1 axis in EGFR wild-type non-small-cell lung cancer. Phytomedicine. 2021;80:153370.","journal-title":"Phytomedicine"},{"key":"1930_CR23","doi-asserted-by":"publisher","first-page":"4505513","DOI":"10.1155\/2022\/4505513","volume":"2022","author":"J Wu","year":"2022","unstructured":"Wu J, Xue R, Wu M, Yin X, Xie B, Meng Q. Nrf2-mediated ferroptosis inhibition exerts a protective effect on acute-on-chronic liver failure. Oxid Med Cell Longev. 2022;2022:4505513.","journal-title":"Oxid Med Cell Longev"},{"issue":"1","key":"1930_CR24","doi-asserted-by":"publisher","first-page":"8347","DOI":"10.1080\/21655979.2021.1987053","volume":"12","author":"S Zheng","year":"2021","unstructured":"Zheng S, Wang C, Yan H, Du Y. Blocking hsa_circ_0074027 suppressed non-small cell lung cancer chemoresistance via the miR-379-5p\/IGF1 axis. Bioengineered. 2021;12(1):8347\u201357.","journal-title":"Bioengineered"},{"issue":"11","key":"1930_CR25","doi-asserted-by":"publisher","first-page":"3361","DOI":"10.1080\/15548627.2021.1872241","volume":"17","author":"J Li","year":"2021","unstructured":"Li J, Liu J, Xu Y, Wu R, Chen X, Song X, Zeh H, Kang R, Klionsky DJ, Wang X, et al. Tumor heterogeneity in autophagy-dependent ferroptosis. Autophagy. 2021;17(11):3361\u201374.","journal-title":"Autophagy"},{"issue":"9","key":"1930_CR26","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.1080\/15548627.2020.1810918","volume":"17","author":"X Chen","year":"2021","unstructured":"Chen X, Li J, Kang R, Klionsky DJ, Tang D. Ferroptosis: machinery and regulation. Autophagy. 2021;17(9):2054\u201381.","journal-title":"Autophagy"},{"key":"1930_CR27","doi-asserted-by":"publisher","first-page":"3150145","DOI":"10.1155\/2019\/3150145","volume":"2019","author":"H Lv","year":"2019","unstructured":"Lv H, Zhen C, Liu J, Yang P, Hu L, Shang P. Unraveling the potential role of glutathione in multiple forms of cell death in cancer therapy. Oxid Med Cell Longev. 2019;2019:3150145.","journal-title":"Oxid Med Cell Longev"},{"issue":"1","key":"1930_CR28","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1186\/s12943-020-01260-z","volume":"19","author":"L Horvath","year":"2020","unstructured":"Horvath L, Thienpont B, Zhao L, Wolf D, Pircher A. Overcoming immunotherapy resistance in non-small cell lung cancer (NSCLC)\u2014novel approaches and future outlook. Mol Cancer. 2020;19(1):141.","journal-title":"Mol Cancer"},{"issue":"1","key":"1930_CR29","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s12967-021-02745-1","volume":"19","author":"J Li","year":"2021","unstructured":"Li J, Lu K, Sun F, Tan S, Zhang X, Sheng W, Hao W, Liu M, Lv W, Han W. Panaxydol attenuates ferroptosis against LPS-induced acute lung injury in mice by Keap1-Nrf2\/HO-1 pathway. J Transl Med. 2021;19(1):96.","journal-title":"J Transl Med"},{"issue":"1","key":"1930_CR30","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1080\/13880209.2018.1492620","volume":"56","author":"ZL Wang","year":"2018","unstructured":"Wang ZL, Wang S, Kuang Y, Hu ZM, Qiao X, Ye M. A comprehensive review on phytochemistry, pharmacology, and flavonoid biosynthesis of Scutellaria baicalensis. Pharm Biol. 2018;56(1):465\u201384.","journal-title":"Pharm Biol"},{"key":"1930_CR31","doi-asserted-by":"publisher","DOI":"10.3390\/biom10010047","author":"T Khan","year":"2019","unstructured":"Khan T, Ali M, Khan A, Nisar P, Jan SA, Afridi S, Shinwari ZK. Anticancer plants: a review of the active phytochemicals, applications in animal models, and regulatory aspects. Biomolecules. 2019. https:\/\/doi.org\/10.3390\/biom10010047.","journal-title":"Biomolecules"},{"key":"1930_CR32","doi-asserted-by":"publisher","first-page":"866282","DOI":"10.3389\/fpls.2022.866282","volume":"13","author":"T Pei","year":"2022","unstructured":"Pei T, Yan M, Huang Y, Wei Y, Martin C, Zhao Q. Specific flavonoids and their biosynthetic pathway in scutellaria baicalensis. Front Plant Sci. 2022;13:866282.","journal-title":"Front Plant Sci"},{"key":"1930_CR33","doi-asserted-by":"publisher","first-page":"821485","DOI":"10.3389\/fphar.2021.821485","volume":"12","author":"HJ Cao","year":"2021","unstructured":"Cao HJ, Zhou W, Xian XL, Sun SJ, Ding PJ, Tian CY, Tian FL, Jiang CH, Fu TT, Zhao S, et al. A mixture of baicalein, wogonin, and oroxylin-A inhibits EMT in the A549 cell line via the PI3K\/AKT-TWIST1-glycolysis pathway. Front Pharmacol. 2021;12:821485.","journal-title":"Front Pharmacol"},{"issue":"3","key":"1930_CR34","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1080\/17425247.2019.1583644","volume":"16","author":"E Zhang","year":"2019","unstructured":"Zhang E, Xing R, Liu S, Li P. Current advances in development of new docetaxel formulations. Expert Opin Drug Deliv. 2019;16(3):301\u201312.","journal-title":"Expert Opin Drug Deliv"},{"key":"1930_CR35","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13030400","author":"S Aishah","year":"2021","unstructured":"Aishah S, Razak A, Mohd Gazzali A, Fisol FA, Abdulbaqi IM, Parumasivam T, Mohtar N, Wahab HA. Advances in nanocarriers for effective delivery of docetaxel in the treatment of lung cancer: an overview. Cancers (Basel). 2021. https:\/\/doi.org\/10.3390\/cancers13030400.","journal-title":"Cancers (Basel)"},{"issue":"13","key":"1930_CR36","doi-asserted-by":"publisher","first-page":"4540","DOI":"10.1002\/cam4.3093","volume":"9","author":"K Katsui","year":"2020","unstructured":"Katsui K, Ogata T, Watanabe K, Katayama N, Kuroda M, Kiura K, Hiraki T, Maeda Y, Toyooka S, Kanazawa S. Radiation pneumonitis after definitive concurrent chemoradiotherapy with cisplatin\/docetaxel for non-small cell lung cancer: analysis of dose-volume parameters. Cancer Med. 2020;9(13):4540\u20139.","journal-title":"Cancer Med"},{"issue":"1","key":"1930_CR37","doi-asserted-by":"publisher","first-page":"10760","DOI":"10.1038\/s41598-017-11404-9","volume":"7","author":"Y Chen","year":"2017","unstructured":"Chen Y, Li J, Chen S, Zhang Y, Hu Y, Zhang G, Yan X, Jiao S. Nab-paclitaxel in combination with cisplatin versus docetaxel plus cisplatin as first-line therapy in non-small cell lung cancer. Sci Rep. 2017;7(1):10760.","journal-title":"Sci Rep"},{"key":"1930_CR38","doi-asserted-by":"publisher","first-page":"1958174","DOI":"10.1155\/2016\/1958174","volume":"2016","author":"AL Furfaro","year":"2016","unstructured":"Furfaro AL, Traverso N, Domenicotti C, Piras S, Moretta L, Marinari UM, Pronzato MA, Nitti M. The Nrf2\/HO-1 axis in cancer cell growth and chemoresistance. Oxid Med Cell Longev. 2016;2016:1958174.","journal-title":"Oxid Med Cell Longev"},{"issue":"11","key":"1930_CR39","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1080\/15384101.2017.1312224","volume":"16","author":"J Wang","year":"2017","unstructured":"Wang J, Liu Z, Hu T, Han L, Yu S, Yao Y, Ruan Z, Tian T, Huang T, Wang M, et al. Nrf2 promotes progression of non-small cell lung cancer through activating autophagy. Cell Cycle. 2017;16(11):1053\u201362.","journal-title":"Cell Cycle"},{"issue":"4","key":"1930_CR40","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.chembiol.2020.02.005","volume":"27","author":"J Liu","year":"2020","unstructured":"Liu J, Kuang F, Kroemer G, Klionsky DJ, Kang R, Tang D. Autophagy-dependent ferroptosis: machinery and regulation. Cell Chem Biol. 2020;27(4):420\u201335.","journal-title":"Cell Chem Biol"},{"issue":"5","key":"1930_CR41","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","volume":"149","author":"SJ Dixon","year":"2012","unstructured":"Dixon SJ, Lemberg KM, Lamprecht MR, Skouta R, Zaitsev EM, Gleason CE, Patel DN, Bauer AJ, Cantley AM, Yang WS, et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell. 2012;149(5):1060\u201372.","journal-title":"Cell"},{"key":"1930_CR42","doi-asserted-by":"publisher","first-page":"111872","DOI":"10.1016\/j.biopha.2021.111872","volume":"141","author":"Y Qin","year":"2021","unstructured":"Qin Y, Qiao Y, Wang D, Tang C, Yan G. Ferritinophagy and ferroptosis in cardiovascular disease: mechanisms and potential applications. Biomed Pharmacother. 2021;141:111872.","journal-title":"Biomed Pharmacother"},{"key":"1930_CR43","doi-asserted-by":"publisher","first-page":"154411","DOI":"10.1016\/j.phymed.2022.154411","volume":"106","author":"J Li","year":"2022","unstructured":"Li J, Yuan J, Li Y, Wang J, Xie Q, Ma R, Wang J, Ren M, Danni L, Zhuo X. d-Borneol enhances cisplatin sensitivity via autophagy dependent EMT signaling and NCOA4-mediated ferritinophagy. Phytomedicine. 2022;106:154411.","journal-title":"Phytomedicine"},{"key":"1930_CR44","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21144908","author":"MM Capelletti","year":"2020","unstructured":"Capelletti MM, Manceau H, Puy H, Peoc\u2019h K. Ferroptosis in liver diseases: an overview. Int J Mol Sci. 2020. https:\/\/doi.org\/10.3390\/ijms21144908.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"1930_CR45","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.chembiol.2020.03.011","volume":"27","author":"A Anandhan","year":"2020","unstructured":"Anandhan A, Dodson M, Schmidlin CJ, Liu P, Zhang DD. Breakdown of an ironclad defense system: the critical role of NRF2 in mediating ferroptosis. Cell Chem Biol. 2020;27(4):436\u201347.","journal-title":"Cell Chem Biol"},{"issue":"1","key":"1930_CR46","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s11658-022-00383-z","volume":"27","author":"Y Li","year":"2022","unstructured":"Li Y, Xu B, Ren X, Wang L, Xu Y, Zhao Y, Yang C, Yuan C, Li H, Tong X, et al. Inhibition of CISD2 promotes ferroptosis through ferritinophagy-mediated ferritin turnover and regulation of p62-Keap1-NRF2 pathway. Cell Mol Biol Lett. 2022;27(1):81.","journal-title":"Cell Mol Biol Lett"},{"key":"1930_CR47","doi-asserted-by":"publisher","first-page":"3920664","DOI":"10.1155\/2022\/3920664","volume":"2022","author":"D Guan","year":"2022","unstructured":"Guan D, Zhou W, Wei H, Wang T, Zheng K, Yang C, Feng R, Xu R, Fu Y, Li C, et al. Ferritinophagy-mediated ferroptosis and activation of keap1\/Nrf2\/HO-1 pathway were conducive to EMT inhibition of gastric cancer cells in action of 2,2-di-pyridineketone hydrazone dithiocarbamate butyric acid ester. Oxidat Med Cell Longevit. 2022;2022:3920664.","journal-title":"Oxidat Med Cell Longevit"},{"issue":"12","key":"1930_CR48","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1038\/nri2448","volume":"8","author":"DM Mosser","year":"2008","unstructured":"Mosser DM, Edwards JP. Exploring the full spectrum of macrophage activation. Nat Rev Immunol. 2008;8(12):958\u201369.","journal-title":"Nat Rev Immunol"},{"key":"1930_CR49","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22136995","author":"AJ Boutilier","year":"2021","unstructured":"Boutilier AJ, Elsawa SF. Macrophage polarization states in the tumor microenvironment. Int J Mol Sci. 2021. https:\/\/doi.org\/10.3390\/ijms22136995.","journal-title":"Int J Mol Sci"},{"key":"1930_CR50","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/1471-2407-10-112","volume":"10","author":"J Ma","year":"2010","unstructured":"Ma J, Liu L, Che G, Yu N, Dai F, You Z. The M1 form of tumor-associated macrophages in non-small cell lung cancer is positively associated with survival time. BMC Cancer. 2010;10:112.","journal-title":"BMC Cancer"},{"issue":"5","key":"1930_CR51","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1038\/s41401-019-0317-6","volume":"41","author":"X Huang","year":"2020","unstructured":"Huang X, Fei GQ, Liu WJ, Ding J, Wang Y, Wang H, Ji JL, Wang X. Adipose-derived mesenchymal stem cells protect against CMS-induced depression-like behaviors in mice via regulating the Nrf2\/HO-1 and TLR4\/NF-kappaB signaling pathways. Acta Pharmacol Sin. 2020;41(5):612\u20139.","journal-title":"Acta Pharmacol Sin"},{"key":"1930_CR52","doi-asserted-by":"publisher","first-page":"911","DOI":"10.3389\/fphar.2018.00911","volume":"9","author":"JF Luo","year":"2018","unstructured":"Luo JF, Shen XY, Lio CK, Dai Y, Cheng CS, Liu JX, Yao YD, Yu Y, Xie Y, Luo P, et al. Activation of Nrf2\/HO-1 pathway by nardochinoid C inhibits inflammation and oxidative stress in lipopolysaccharide-stimulated macrophages. Front Pharmacol. 2018;9:911.","journal-title":"Front Pharmacol"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-024-01930-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-024-01930-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-024-01930-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,26]],"date-time":"2024-07-26T20:09:40Z","timestamp":1722024580000},"score":1,"resource":{"primary":{"URL":"https:\/\/eurjmedres.biomedcentral.com\/articles\/10.1186\/s40001-024-01930-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,26]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1930"],"URL":"https:\/\/doi.org\/10.1186\/s40001-024-01930-4","relation":{},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,26]]},"assertion":[{"value":"20 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures involving animals were approved by the Animal Ethics Committee of Changzheng Hospital, Naval Medical University (No. LLSP20220420).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests in this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"387"}}